H. Lundbeck A/S (LUN) to Release Q4 2007 Earnings March 4

H. Lundbeck A/S (CPG:LUN) will release the fourth quarter earnings for 2007 on March 4.

Based in Denmark, H. Lundbck engages within the pharmaceuticals industry.  The company develops products to treat disorders of the central nervous system.  Key areas of development involves treatment for depression, brain disorders such as schizophrenia and epilepsy, neurological disorders, Parkinsons disease, Alzheimers disease, autoimmune diseases, such as multiple sclerosis and sleep disorders such as insomnia.  The company’s primary focus is on the treatment of depression and psychosis.

Lundbeck products include Cipralex, an antidepressant, Azilect, for Parkinson’s disease, Serdolect, for schizophrenia and Ebixa to treat moderate to severe Alzheimer’s disease.

While the company is active globally, the largest markets are in the United States and Europe.

For more Earnings related events or to post your own events, visit:

http://events.finditt.com/Events_list.aspx?catid=13